Title : Effect of Vaccinium macrocarpon on MK-801-induced psychosis in mice - Shukla_2018_Indian.J.Pharmacol_50_227 |
Author(s) : Shukla D , Maheshwari RA , Patel K , Balaraman R , Sen AK |
Ref : Indian J Pharmacol , 50 :227 , 2018 |
Abstract :
OBJECTIVES: This study was aimed to investigate the effect of aqueous cranberry extract (ACE) on MK-801-induced psychosis in mice. MATERIALS AND METHODS: MK-801-treated mice were administered ACE (1 and 2 g/kg, p.o.) for 14 days. Various behavioral parameters and neurochemical estimations such as dopamine (DA), 5-hydroxytryptamine (5-HT), norepinephrine (NE), gamma-aminobutyric acid (GABA), glutamate, and glycine as well as markers of oxidative stress such as nitrite levels were measured. RESULTS: Psychosis-induced mice showed a significant elevation of immobility time in forced swim test, locomotor activity, and reduction in time of permanency in rota-rod test, escape latency time in Cook's pole test while treatment with ACE showed a significant alteration in above-mentioned behavioral parameters in MK-801-induced psychosis. Moreover, MK-801-induced psychosis in the mice showed a significant increase in DA, 5-HT, and NA levels and decrease in GABA, glutamate, and glycine levels in the brain. In contrast, treatment with ACE at both doses remarkably altered the neurochemical parameters. In addition, ACE-treated mice showed a substantial reduction in acetylcholinesterase, D-amino acid oxidase enzyme activity, and nitrite levels which were elevated by the administration of MK-801. CONCLUSIONS: Treatment with ACE once for 14 days (1 and 2 g/kg) significantly ameliorated the behavioral symptoms in experimentally induced psychosis by virtue of neuromodulation and decreased oxidative stress. |
PubMedSearch : Shukla_2018_Indian.J.Pharmacol_50_227 |
PubMedID: 30636825 |
Shukla D, Maheshwari RA, Patel K, Balaraman R, Sen AK (2018)
Effect of Vaccinium macrocarpon on MK-801-induced psychosis in mice
Indian J Pharmacol
50 :227
Shukla D, Maheshwari RA, Patel K, Balaraman R, Sen AK (2018)
Indian J Pharmacol
50 :227